The MEA peripheral vascular devices market is expected to grow from US$ 534.63 million in 2021 to US$ 793.82 million by 2028; it is estimated to register a CAGR of 5.8% from 2021 to 2028. In July 2021, Terumo Medical Corporation introduced its Azur vascular plug, which is compatible with a microcatheter to occlude arteries up to 8 mm in diameter. A new addition to Terumo’s embolization portfolio, the Azur device is indicated for use to reduce or block the rate of blood flow in arteries of the peripheral vasculature. Moreover, in March 2021, Varian Medical Systems, Inc. invested in Bendit Technologies Ltd., a medical device company, developing the Bendit steerable microcatheters for use by interventionalists performing minimally invasive peripheral vascular procedures. These devices can deliver diagnostic, embolic, or restorative materials into the vasculature. Such advancements based on modern technologies are likely to introduce new trends in the peripheral vascular devices market across the region during the forecast period.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA peripheral vascular devices market is expected to grow at a notable CAGR during the forecast period.
MEA Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
MEA Peripheral Vascular Devices Market Segmentation
The MEA peripheral vascular devices market is segmented based on product, end user, and country. Based on product, the MEA peripheral vascular devices market is segmented into peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. Further, the peripheral vascular stents segment dominated the market in 2021. Based on end user, the MEA peripheral vascular devices market is segmented into hospitals & clinics, ambulatory care centers, specialty clinics, and others. Further, the hospitals & clinics segment dominated the market in 2021. Based on country, the MEA peripheral vascular devices market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. Further, Saudi Arabia dominated the market in 2021.
Abbott, B. Braun Melsungen AG, BD, Boston Scientific Corporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, and Terumo Corporation are among the leading companies operating in the MEA peripheral vascular devices market.